Outcomes of marginal donors for lung transplantation after ex vivo lung perfusion: A systematic review and meta-analysis
- PMID: 31548078
- DOI: 10.1016/j.jtcvs.2019.07.087
Outcomes of marginal donors for lung transplantation after ex vivo lung perfusion: A systematic review and meta-analysis
Abstract
Objective: Ex vivo lung perfusion (EVLP) is reportedly a useful strategy that permits marginal donor lungs to be evaluated and reconditioned for successful lung transplantation (LTx). This systematic review and meta-analysis was performed to evaluate the outcomes of EVLP conducted for marginal donor lungs.
Methods: We searched PubMed, the Cochrane Library, and Embase to select studies describing the results of LTx following EVLP for marginal donor lungs compared with standard LTx without EVLP. We performed a meta-analysis to examine donor baseline characteristics, recipient baseline characteristics, and postoperative outcomes.
Results: Of 1380 studies, 8 studies involving 1191 patients met the inclusion criteria. Compared with the non-EVLP group (ie, standard LTx without EVLP), the EVLP group (ie, EVLP of marginal donors following LTx) had similar donor age and sex and recipient baseline age, sex, body mass index, bridge by ventilator/extracorporeal life support/extracorporeal membrane oxygenation, and rate of double LTx but more abnormal donor lung radiographs (P = .0002), a higher smoking history rate (P = .03), and worse donor arterial oxygen tension/inspired oxygen fraction (P < .00001). However, there were no significant differences in outcomes between the EVLP and non-EVLP groups with respect to the length of postoperative intubation, postoperative extracorporeal life support/extracorporeal membrane oxygenation use, length of intensive care unit stay, length of hospital stay, 72-hour primary graft dysfunction of grade 3, 30-day survival, or 1-year survival (all P values > .05).
Conclusions: Posttransplant outcomes were similar between EVLP-treated LTx and standard LTx without EVLP, although the quality of donor lungs was worse with EVLP-treated LTx.
Keywords: ex vivo lung perfusion; lung transplantation; marginal donor lung; meta-analysis.
Copyright © 2019 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
Comment in
-
Commentary: A positively out-of-body experience for lungs.J Thorac Cardiovasc Surg. 2020 Feb;159(2):732-733. doi: 10.1016/j.jtcvs.2019.07.070. Epub 2019 Aug 22. J Thorac Cardiovasc Surg. 2020. PMID: 31530371 No abstract available.
-
Commentary: Leveling up the evidence!J Thorac Cardiovasc Surg. 2020 Feb;159(2):731. doi: 10.1016/j.jtcvs.2019.08.011. Epub 2019 Sep 5. J Thorac Cardiovasc Surg. 2020. PMID: 31619327 No abstract available.
Similar articles
-
An observational study of Donor Ex Vivo Lung Perfusion in UK lung transplantation: DEVELOP-UK.Health Technol Assess. 2016 Nov;20(85):1-276. doi: 10.3310/hta20850. Health Technol Assess. 2016. PMID: 27897967 Free PMC article.
-
Standard donor lung procurement with normothermic ex vivo lung perfusion: A prospective randomized clinical trial.J Heart Lung Transplant. 2017 Jul;36(7):744-753. doi: 10.1016/j.healun.2017.02.011. Epub 2017 Feb 20. J Heart Lung Transplant. 2017. PMID: 28314503 Clinical Trial.
-
First experience with ex vivo lung perfusion for initially discarded donor lungs in the Netherlands: a single-centre study.Eur J Cardiothorac Surg. 2019 May 1;55(5):920-926. doi: 10.1093/ejcts/ezy373. Eur J Cardiothorac Surg. 2019. PMID: 30496383
-
The Conversional Efficacy of Ex Vivo Lung Perfusion and Clinical Outcomes in Patients Undergoing Transplantation of Donor Lungs by Ex Vivo Lung Perfusion: A Meta-Analysis.Ann Transplant. 2019 Dec 27;24:647-660. doi: 10.12659/AOT.919242. Ann Transplant. 2019. PMID: 31879416 Free PMC article.
-
Ex-vivo lung perfusion.Curr Opin Anaesthesiol. 2020 Feb;33(1):50-54. doi: 10.1097/ACO.0000000000000804. Curr Opin Anaesthesiol. 2020. PMID: 31688085 Review.
Cited by
-
A year in general thoracic surgery published in the Journal of Thoracic and Cardiovascular Surgery: 2020.J Thorac Cardiovasc Surg. 2021 Jul;162(1):253-258. doi: 10.1016/j.jtcvs.2021.03.106. Epub 2021 Apr 20. J Thorac Cardiovasc Surg. 2021. PMID: 34024614 Free PMC article. No abstract available.
-
Epidemiology and Long-Term Outcomes in Thoracic Transplantation.J Cardiovasc Dev Dis. 2023 Sep 18;10(9):397. doi: 10.3390/jcdd10090397. J Cardiovasc Dev Dis. 2023. PMID: 37754826 Free PMC article. Review.
-
Update in lung transplantation: anesthetic considerations.Ann Transl Med. 2023 Oct 25;11(11):389. doi: 10.21037/atm-22-4602. Epub 2023 Jul 6. Ann Transl Med. 2023. PMID: 37970597 Free PMC article. Review.
-
The new frontier of hepatitis C virus (HCV)-mismatched heart and lung transplantation.Ann Transl Med. 2019 Dec;7(Suppl 8):S279. doi: 10.21037/atm.2019.11.123. Ann Transl Med. 2019. PMID: 32015998 Free PMC article. No abstract available.
-
Is logistically motivated ex vivo lung perfusion a good idea?Front Transplant. 2022 Dec 14;1:988950. doi: 10.3389/frtra.2022.988950. eCollection 2022. Front Transplant. 2022. PMID: 38994392 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous